Nitroflurbiprofen
Alternative Names: Flurbinitroxybutylester; Flurbiprofen nitroxybutylester; HCT 1026; NO-flurbiprofenLatest Information Update: 16 Sep 2009
At a glance
- Originator NicOx
- Class Antidementias; Neuroprotectants; Nonsteroidal anti-inflammatories; Propionic acids; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Coronary artery restenosis; Inflammation; Osteitis deformans; Overactive bladder; Postmenopausal osteoporosis; Skin disorders; Urinary incontinence; Urticaria
Most Recent Events
- 03 Nov 2006 Data presented at the 36th Annual Meeting of the Society for Neuroscience (SfN-2006) have been added to the Parkinson's disease pharmacodynamics section
- 24 Mar 2006 No development reported - Phase-II for Osteitis deformans in United Kingdom (PO)
- 24 Mar 2006 No development reported - Phase-II for Overactive bladder in France (PO)